SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001633070-22-000016
Filing Date
2022-05-05
Accepted
2022-05-05 16:01:50
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axla-20220331.htm   iXBRL 10-Q 1339529
2 EX-31.1 exhibit311q12022.htm EX-31.1 10566
3 EX-31.2 exhibit312q12022.htm EX-31.2 10419
4 EX-32.1 exhibit321q12022.htm EX-32.1 7076
10 GRAPHIC axla-20220331_g1.jpg GRAPHIC 86136
  Complete submission text file 0001633070-22-000016.txt   5668097

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axla-20220331.xsd EX-101.SCH 31822
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axla-20220331_cal.xml EX-101.CAL 61935
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axla-20220331_def.xml EX-101.DEF 126017
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axla-20220331_lab.xml EX-101.LAB 490696
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axla-20220331_pre.xml EX-101.PRE 302548
61 EXTRACTED XBRL INSTANCE DOCUMENT axla-20220331_htm.xml XML 711611
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38901 | Film No.: 22896037
SIC: 2836 Biological Products, (No Diagnostic Substances)